Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Chevalier

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Molecular Psychiatry|January 7, 2009
A SNAP25 promoter variant is associated with early-onset bipolar disorder and a high expression level in brainB Etain, A Dumaine, F Mathieu, et al.
Clinical Genetics|June 28, 2007
Large deletions in the CFTR gene: clinics and genetics in Swiss patients with CFM Schneider, C Hirt, C Casaulta, et al.
Frontiers in Immunology|February 3, 2025
Mass cytometry: exploring the immune landscape of systemic autoimmune and inflammatory diseases in the past fourteen yearsAïcha Kante, Mathieu F Chevalier, Damien Sène, et al.
The Journal of Infection|February 13, 2017
Interleukin-1 receptor antagonist, a biomarker of response to anti-TB treatment in HIV/TB co-infected patientsJanin Nouhin, Polidy Pean, Yoann Madec, et al.
International Clinical Psychopharmacology|June 1, 1996
Citalopram versus fluoxetine: a double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practiceM Patris, J M Bouchard, T Bougerol, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 5, 2015
Rosuvastatin Is Effective to Decrease CD8 T-Cell Activation Only in HIV-Infected Patients With High Residual T-Cell Activation Under Antiretroviral TherapyLaurence Weiss, Mathieu F Chevalier, Lambert Assoumou, et al.
Cancer Immunology Research|January 31, 2019
Intravesical Ty21a Vaccine Promotes Dendritic Cells and T Cell-Mediated Tumor Regression in the MB49 Bladder Cancer ModelSonia Domingos-Pereira, Karthik Sathiyanadan, Stefano La Rosa, et al.
Human Genetics|August 1, 1997
A new mutation, 3905insT, accounts for 4.8% of 1173 CF chromosomes in Switzerland and causes a severe phenotypeM Hergersberg, J Balakrishnan, T Bettecken, et al.
Oncoimmunology|October 10, 2015
High-throughput monitoring of human tumor-specific T-cell responses with large peptide poolsMathieu F Chevalier, Sara Bobisse, Carla Costa-Nunes, et al.
Blood|July 12, 2022
Immune landscape after allo-HSCT: TIGIT- and CD161-expressing CD4 T cells are associated with subsequent leukemia relapseViviane Gournay, Nicolas Vallet, Vivien Peux, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Molecular Psychiatry|January 7, 2009
A SNAP25 promoter variant is associated with early-onset bipolar disorder and a high expression level in brainB Etain, A Dumaine, F Mathieu, et al.
Clinical Genetics|June 28, 2007
Large deletions in the CFTR gene: clinics and genetics in Swiss patients with CFM Schneider, C Hirt, C Casaulta, et al.
Frontiers in Immunology|February 3, 2025
Mass cytometry: exploring the immune landscape of systemic autoimmune and inflammatory diseases in the past fourteen yearsAïcha Kante, Mathieu F Chevalier, Damien Sène, et al.
The Journal of Infection|February 13, 2017
Interleukin-1 receptor antagonist, a biomarker of response to anti-TB treatment in HIV/TB co-infected patientsJanin Nouhin, Polidy Pean, Yoann Madec, et al.
International Clinical Psychopharmacology|June 1, 1996
Citalopram versus fluoxetine: a double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practiceM Patris, J M Bouchard, T Bougerol, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 5, 2015
Rosuvastatin Is Effective to Decrease CD8 T-Cell Activation Only in HIV-Infected Patients With High Residual T-Cell Activation Under Antiretroviral TherapyLaurence Weiss, Mathieu F Chevalier, Lambert Assoumou, et al.
Cancer Immunology Research|January 31, 2019
Intravesical Ty21a Vaccine Promotes Dendritic Cells and T Cell-Mediated Tumor Regression in the MB49 Bladder Cancer ModelSonia Domingos-Pereira, Karthik Sathiyanadan, Stefano La Rosa, et al.
Human Genetics|August 1, 1997
A new mutation, 3905insT, accounts for 4.8% of 1173 CF chromosomes in Switzerland and causes a severe phenotypeM Hergersberg, J Balakrishnan, T Bettecken, et al.
Oncoimmunology|October 10, 2015
High-throughput monitoring of human tumor-specific T-cell responses with large peptide poolsMathieu F Chevalier, Sara Bobisse, Carla Costa-Nunes, et al.
Blood|July 12, 2022
Immune landscape after allo-HSCT: TIGIT- and CD161-expressing CD4 T cells are associated with subsequent leukemia relapseViviane Gournay, Nicolas Vallet, Vivien Peux, et al.
Pageof 12